Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.

Abstract: Apurinic/apuyrimidinic endonuclease 1/Redox Factor-1 (APE/Ref-1) inhibitors are provided along with methods of using the same. The inhibitor has the structure of Formula I: or a pharmaceutically acceptable salt thereof. n is an integer from 4 to 14, X and X? are each independently H or OH, and Y and Y? are each independently H or OH.

Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.

Abstract: Disclosed herein are tumor-targeting peptides and methods of treating cancer with the combination of a tumor-targeting peptide and a chemotherapeutic agent.

Abstract: Apurinic/apuyrimidinic endonuclease 1/Redox Factor-1 (APE/Ref-1) inhibitors are provided along with methods of using the same. The inhibitor has the structure of Formula I: or a pharmaceutically acceptable salt thereof. n is an integer from 4 to 14, X and X? are each independently H or OH, and Y and Y? are each independently H or OH.

Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.

Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.

Abstract: Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.

Abstract: Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.

Abstract: Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.

Abstract: Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.

Abstract: Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.

Abstract: A command decoder circuit generates command signals for performing internal operations and according to external command signals, according to values of the write latency values and whether write latency is an even numbered or odd-numbered value.

Abstract: An organic light-emitting display includes a substrate, a thin film transistor on the substrate, an organic light-emitting diode electrically connected to the thin film transistor, and a photo sensor having a plurality of photo diodes connected to one another in parallel.

Abstract: A charge pump circuit comprises a decoder for generating a plurality of control signals, a ring oscillator an output frequency of which varies according to the plurality of the control signals, a charge pump for generating a high voltage, which is higher than an external voltage, according to an output of the ring oscillator, and a fuse tuning unit for fixing one of the plurality of the control signals.

Abstract: An organic light emitting display and a driving method for the display. Pixel circuits of the display, allow an increase in a data current in order to increase speed of charging the data current in a data line. Consequently, writing speed of data in the data line is higher with higher data current. The pixel circuit adjusts drive current passing through organic light emitting diodes to prevent an increase in the drive current due to the increased data current. The driving method divides non-emitting periods of the organic light emitting diode within one frame period. Therefore, the organic light emitting diode emits light at least twice within one frame period resulting in shorter non-emitting periods. Shortening the length of the non-emitting periods prevents flicker and image sticking even when the duty ratio or the overall duration of the emitting period remains constant.

Abstract: An apparatus for digitizing a brightness of a light emitting display includes a brightness measuring part for generating a brightness data for a number of photographic areas of the light emitting display. The apparatus also includes a calculating part for calculating: a mean value of the generated brightness data; a standard deviation of the generated brightness data; a standard deviation/mean value, for the number of photographic areas. The apparatus also includes a storing part for storing the mean value, the standard deviation and the standard deviation/mean value calculated by the calculating part. The apparatus may also include a determining part for comparing the standard deviation/mean value with a reference value, and correspondingly determining whether the performance of the light emitting display is favorable or unfavorable.

Abstract: A method for obtaining broadcasting channel information and registering for reception of multicast based Internet protocol (IP) TV broadcasting service in a subscriber network is provided. The method for receiving multicast based IP TV broadcasting service by a terminal connected to a subscriber network through an access router, includes: completing authentication of the terminal and subscriber; accessing a web server providing an electronic program guide (EPG) and receiving information on at least one or more channels permitted to the terminal; providing at least one or more selection units by using graphic user interface (GUI) so that a channel is selected based on the channel information; and according to the selected channel, generating and transmitting a multicast socket.

Abstract: Three-dimensional single or multilayer polymer scaffolds for use in tissue engineering and other applications are provided. These scaffolds typically include at least two layers of biodegradable polymer of similar thickness, wherein each layer of polymer further includes a plurality of substantially uniform structural features having predetermined geometries, and wherein each layer of polymer is attached to the other layers of polymer to form predefined spatial relationships between the structural features of each layer.

Abstract: Provided is directed to a delay locked loop control circuit capable of reducing a test time and preventing a yield from being reduced, by preventing a failure due to a charge sharing and a failure in a specific frequency and voltage due to a noise of a feedback clock, by means of including: a level setting unit for setting an initial level of a locked state signal, which is decided whether or not phases of a reference clock and a feedback clock are aligned; a signal generation unit for generating a third control signal according to a first control signal comparing phases of the reference clock and the feedback clock, and a second control signal checking out phases of the reference clock and the feedback clock in every predetermined time; a level maintaining unit for maintaining a level of the locked state signal according to the locked state signal and a fourth control signal comparing a signal delaying the feedback clock for a predetermined time with the reference clock; a detection unit for varying a level